See more : Queensland Gold Hills Corp. (MNNFF) Income Statement Analysis – Financial Results
Complete financial analysis of Zhejiang NHU Company Ltd. (002001.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang NHU Company Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- WPIL Limited (WPIL.BO) Income Statement Analysis – Financial Results
- Luminex Corporation (LMNX) Income Statement Analysis – Financial Results
- TINC NV (0R7T.L) Income Statement Analysis – Financial Results
- Midway Limited (MWY.AX) Income Statement Analysis – Financial Results
- HangZhou Everfine Photo-e-info Co., Ltd. (300306.SZ) Income Statement Analysis – Financial Results
Zhejiang NHU Company Ltd. (002001.SZ)
About Zhejiang NHU Company Ltd.
Zhejiang NHU Company Ltd. engages in the production and sale of nutritional products, flavor and fragrances, new polymer materials, and APIs in China. The company offers nutrition products, such as vitamin E, vitamin A, vitamin C, DL-Methionine, vitamin D3, biotin, coenzyme Q10, carotenoids, etc. for used in feed additives, and nutrition supplements of food, beverages, health food, etc.; and flavor and fragrance products comprising linalool series, citral series, cis-3-hexenol series, methyl dihydrojasmonate, raspberry ketone, and ligustral for used in personal care, cosmetic, and food fields. It also provides polymer materials, including polyphenylene sulfide and poly phthalamide for used in electronic and electrical, automotive, environmental protection, etc.; and APIs, such as moxifloxacin hydrochloride, vitamin A, vitamin D3, etc. to use as active pharmaceutical ingredients for processing and producing pharmaceutical preparations. The company was incorporated in 1999 and is based in Xinchang, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.12B | 15.93B | 14.80B | 10.31B | 7.62B | 8.68B | 6.24B | 4.70B | 3.82B | 4.16B | 4.24B | 3.63B | 3.80B | 3.45B | 2.90B | 3.31B | 1.75B | 1.59B | 1.26B | 1.13B | 950.97M | 691.28M | 539.10M |
| Cost of Revenue | 10.36B | 10.05B | 8.21B | 4.73B | 4.02B | 4.05B | 3.09B | 2.56B | 2.78B | 2.50B | 2.63B | 2.05B | 2.01B | 1.66B | 1.30B | 1.17B | 1.39B | 1.34B | 1.01B | 902.32M | 746.82M | 533.12M | 424.89M |
| Gross Profit | 4.75B | 5.89B | 6.59B | 5.59B | 3.60B | 4.63B | 3.15B | 2.13B | 1.04B | 1.66B | 1.61B | 1.59B | 1.79B | 1.79B | 1.59B | 2.14B | 358.92M | 245.19M | 242.42M | 231.77M | 204.15M | 158.17M | 114.21M |
| Gross Profit Ratio | 31.45% | 36.94% | 44.50% | 54.17% | 47.28% | 53.37% | 50.47% | 45.43% | 27.22% | 39.98% | 37.99% | 43.68% | 47.11% | 51.84% | 54.98% | 64.72% | 20.53% | 15.43% | 19.29% | 20.44% | 21.47% | 22.88% | 21.19% |
| Research & Development | 887.80M | 858.95M | 782.66M | 545.56M | 434.13M | 457.07M | 336.24M | 253.41M | 201.93M | 223.92M | 190.45M | 160.41M | 145.33M | 100.93M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 149.61M | 142.75M | 124.23M | 133.90M | 120.17M | 137.12M | 89.75M | 78.37M | 75.35M | 82.46M | 61.77M | 64.07M | 69.01M | 65.86M | 222.74M | 191.34M | 97.74M | 82.83M | 62.75M | 76.86M | 60.03M | 43.98M | 33.60M |
| Selling & Marketing | 158.32M | 122.26M | 107.04M | 312.96M | 232.08M | 252.10M | 211.39M | 149.42M | 157.14M | 115.36M | 97.91M | 65.29M | 85.49M | 96.50M | 71.75M | 72.89M | 60.59M | 59.89M | 47.75M | 46.17M | 30.56M | 22.49M | 17.73M |
| SG&A | 307.92M | 265.01M | 231.27M | 446.85M | 352.25M | 389.21M | 301.14M | 227.79M | 232.48M | 197.83M | 159.67M | 129.36M | 154.50M | 162.36M | 294.48M | 264.23M | 158.33M | 142.72M | 110.50M | 123.03M | 90.59M | 66.47M | 51.33M |
| Other Expenses | 298.62M | 311.97M | 278.60M | 282.43M | 261.17M | 9.59M | -299.77K | 37.77M | 29.56M | 13.89M | 37.44M | -31.58M | 17.64M | 9.08M | 13.80M | 1.37M | 1.15M | 2.90M | 5.59M | 11.39M | 8.36M | 1.60M | 9.73M |
| Operating Expenses | 1.49B | 1.44B | 1.29B | 1.27B | 1.05B | 1.13B | 868.34M | 702.06M | 627.10M | 589.56M | 518.30M | 402.42M | 414.24M | 394.10M | 317.86M | 295.86M | 166.64M | 145.18M | 112.17M | 123.89M | 91.44M | 68.44M | 53.90M |
| Cost & Expenses | 11.86B | 11.48B | 9.50B | 6.00B | 5.07B | 5.18B | 3.96B | 3.26B | 3.41B | 3.09B | 3.15B | 2.45B | 2.43B | 2.05B | 1.62B | 1.46B | 1.56B | 1.49B | 1.13B | 1.03B | 838.26M | 601.56M | 478.79M |
| Interest Income | 126.32M | 153.45M | 164.42M | 42.38M | 27.77M | 55.24M | 17.47M | 20.44M | 33.30M | 31.04M | 25.21M | 26.31M | 28.71M | 19.97M | -0.52 | -0.83 | -0.19 | 3.71M | 5.99M | 6.90M | 2.35M | 3.29M | 4.68M |
| Interest Expense | 319.91M | 329.24M | 337.75M | 249.05M | 190.71M | 86.31M | 61.97M | 51.78M | 38.96M | 43.14M | 41.12M | 47.90M | 43.85M | 39.28M | 55.95M | 186.66M | 80.15M | 56.34M | 33.69M | 25.85M | 22.73M | 19.83M | 20.51M |
| Depreciation & Amortization | 1.71B | 1.40B | 1.23B | 865.61M | 563.05M | 457.81M | 369.93M | 346.38M | 377.39M | 346.30M | 300.62M | 244.51M | 206.68M | 179.47M | 140.83M | 115.32M | 122.12M | 110.22M | 68.70M | 62.96M | 56.11M | 50.97M | 29.46M |
| EBITDA | 5.25B | 5.88B | 6.58B | 5.18B | 3.31B | 4.18B | 2.54B | 1.75B | 840.51M | 1.41B | 1.40B | 1.33B | 1.59B | 1.53B | 1.42B | 1.96B | 314.40M | 213.67M | 191.41M | 196.08M | 188.82M | 155.71M | 73.07M |
| EBITDA Ratio | 34.72% | 38.19% | 44.99% | 50.65% | 43.62% | 48.40% | 41.73% | 41.15% | 23.95% | 34.05% | 33.66% | 38.69% | 42.37% | 45.49% | 49.46% | 60.15% | 18.51% | 13.43% | 15.23% | 17.29% | 19.86% | 22.52% | 13.55% |
| Operating Income | 3.26B | 4.31B | 5.08B | 4.16B | 2.57B | 3.63B | 2.12B | 1.47B | 469.38M | 1.01B | 1.04B | 1.12B | 1.34B | 1.33B | 1.20B | 1.64B | 110.72M | 50.09M | 88.29M | 98.37M | 103.11M | 84.80M | 43.61M |
| Operating Income Ratio | 21.57% | 27.07% | 34.35% | 40.37% | 33.68% | 41.81% | 33.98% | 31.30% | 12.28% | 24.15% | 24.51% | 30.86% | 35.20% | 38.73% | 41.51% | 49.55% | 6.33% | 3.15% | 7.03% | 8.67% | 10.84% | 12.27% | 8.09% |
| Total Other Income/Expenses | -6.57M | -74.55M | -84.18M | -54.34M | 2.13M | 9.59M | -299.77K | -851.89K | -6.26M | 10.87M | 20.45M | -101.46M | -1.26M | -57.48M | -59.92M | -205.17M | -80.69M | -70.38M | -46.10M | 8.90M | 6.88M | 105.77K | 8.95M |
| Income Before Tax | 3.25B | 4.24B | 5.03B | 4.11B | 2.57B | 3.64B | 2.12B | 1.50B | 481.18M | 1.02B | 1.06B | 1.02B | 1.35B | 1.33B | 1.22B | 1.64B | 111.59M | 46.88M | 89.01M | 107.27M | 109.98M | 84.91M | 52.56M |
| Income Before Tax Ratio | 21.52% | 26.60% | 34.00% | 39.85% | 33.71% | 41.92% | 33.97% | 31.94% | 12.59% | 24.41% | 24.99% | 28.07% | 35.55% | 38.48% | 41.95% | 49.61% | 6.38% | 2.95% | 7.08% | 9.46% | 11.57% | 12.28% | 9.75% |
| Income Tax Expense | 528.13M | 599.84M | 690.51M | 532.66M | 392.14M | 541.26M | 404.29M | 274.64M | 91.34M | 208.45M | 177.02M | 169.03M | 187.47M | 167.68M | 100.63M | 195.97M | 35.35M | 21.09M | 29.31M | 33.76M | 36.54M | 30.48M | 6.71M |
| Net Income | 2.70B | 3.62B | 4.36B | 3.56B | 2.17B | 3.08B | 1.70B | 1.20B | 402.07M | 808.04M | 882.12M | 850.17M | 1.16B | 1.10B | 1.02B | 1.37B | 77.07M | 28.95M | 61.18M | 72.61M | 69.27M | 50.85M | 42.28M |
| Net Income Ratio | 17.89% | 22.72% | 29.44% | 34.55% | 28.46% | 35.46% | 27.34% | 25.61% | 10.52% | 19.40% | 20.82% | 23.41% | 30.61% | 31.93% | 35.14% | 41.48% | 4.41% | 1.82% | 4.87% | 6.40% | 7.28% | 7.36% | 7.84% |
| EPS | 0.87 | 1.18 | 1.41 | 1.15 | 0.70 | 0.99 | 0.64 | 0.45 | 0.15 | 0.30 | 0.33 | 0.32 | 0.44 | 0.44 | 0.60 | 0.56 | 0.03 | 0.01 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 |
| EPS Diluted | 0.87 | 1.18 | 1.41 | 1.15 | 0.70 | 0.99 | 0.64 | 0.45 | 0.15 | 0.30 | 0.33 | 0.32 | 0.44 | 0.44 | 0.60 | 0.56 | 0.03 | 0.01 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 |
| Weighted Avg Shares Out | 3.11B | 3.07B | 3.08B | 3.09B | 3.09B | 3.10B | 2.67B | 2.68B | 2.66B | 2.67B | 2.67B | 2.67B | 2.67B | 2.51B | 1.71B | 2.45B | 2.40B | 2.42B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B |
| Weighted Avg Shares Out (Dil) | 3.11B | 3.07B | 3.08B | 3.09B | 3.09B | 3.10B | 2.67B | 2.68B | 2.66B | 2.67B | 2.67B | 2.67B | 2.67B | 2.51B | 1.71B | 2.45B | 2.40B | 2.42B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B |
Source: https://incomestatements.info
Category: Stock Reports